$NVMI
NOVA LTD. Stock $nvmi

$nvmi Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000117891324000649 Filed on February 20, 2024

Income Statement

Concept	2023 Q4	2023
Revenue	$134.2M	$517.9M
YoY Change	-11.25%	-9.25%
Cost Of Revenue	$60.21M	$224.7M
YoY Change	-17.45%	-11.43%
Gross Profit	$74.01M	$293.2M
YoY Change	-5.48%	-7.51%
Gross Profit Margin	55.14%	56.61%
Selling, General & Admin	$19.06M	$72.87M
YoY Change	-3.45%	-4.84%
% of Gross Profit	25.75%	24.86%
Research & Development	$21.29M	$88.04M
YoY Change	-18.76%	-2.67%
% of Gross Profit	28.77%	30.03%
Depreciation & Amortization	$4.201M	$10.34M
YoY Change	6.25%	19.99%
% of Gross Profit	5.68%	3.53%
Operating Expenses	$40.35M	$160.9M
YoY Change	-2.48%	-3.67%
Operating Profit	$33.66M	$132.3M
YoY Change	-8.83%	-11.78%
Interest Expense	$7.283M	$22.44M
YoY Change	237.64%	164.64%
% of Operating Profit	21.64%	16.96%
Other Income/Expense, Net
YoY Change
Pretax Income	$40.95M	$154.7M
YoY Change	4.77%	-2.34%
Income Tax	$2.877M	$18.39M
% Of Pretax Income	7.03%	11.89%
Net Earnings	$38.07M	$136.3M
YoY Change	5.46%	-2.78%
Net Earnings / Revenue	28.36%	26.32%
Basic Earnings Per Share		$4.73
Diluted Earnings Per Share	$1.19	$4.28
COMMON SHARES
Basic Shares Outstanding	29.01M shares	28.83K shares
Diluted Shares Outstanding		32.09K shares

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$515.2M	$443.7M
YoY Change	19.35%	18.79%
Cash & Equivalents	$107.6M	$107.6M
Short-Term Investments	$407.6M	$336.1M
Other Short-Term Assets	$17.08M	$17.08M
YoY Change	26.3%	26.3%
Inventory	$138.2M	$138.2M
Prepaid Expenses	$11.00M
Receivables	$111.3M	$111.3M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$710.2M	$710.2M
YoY Change	15.87%	15.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$66.87M	$108.7M
YoY Change	19.66%	7.9%
Goodwill	$50.08M
YoY Change	2.19%
Intangibles	$39.18M
YoY Change	-10.1%
Long-Term Investments	$191.4M	$191.4M
YoY Change	24.3%	24.3%
Other Assets	$3.259M	$34.24M
YoY Change	240.54%	43.58%
Total Long-Term Assets	$423.6M	$423.6M
YoY Change	14.13%	14.13%
TOTAL ASSETS
Total Short-Term Assets	$710.2M	$710.2M
Total Long-Term Assets	$423.6M	$423.6M
Total Assets	$1.134B	$1.134B
YoY Change	15.21%	15.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$35.16M	$35.16M
YoY Change	-17.72%	-17.72%
Accrued Expenses	$6.703M	$6.703M
YoY Change	12.32%	-85.78%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$197.7M	$197.7M
YoY Change
Total Short-Term Liabilities	$322.8M	$322.8M
YoY Change	140.78%	140.78%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$6.545M	$49.67M
YoY Change	-9.02%	-8.85%
Total Long-Term Liabilities	$60.24M	$49.67M
YoY Change	-77.1%	-80.2%
TOTAL LIABILITIES
Total Short-Term Liabilities	$322.8M	$322.8M
Total Long-Term Liabilities	$60.24M	$49.67M
Total Liabilities	$383.1M	$383.1M
YoY Change	-3.55%	-3.55%
SHAREHOLDERS EQUITY
Retained Earnings	$614.4M
YoY Change	28.51%
Common Stock	$139.7M
YoY Change	15.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$750.8M	$750.8M
YoY Change
Total Liabilities & Shareholders Equity	$1.134B	$1.134B
YoY Change	15.21%	15.21%

Cashflow Statement

Concept	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$38.07M	$136.3M
YoY Change	5.46%	-2.78%
Depreciation, Depletion And Amortization	$4.201M	$10.34M
YoY Change	6.25%	19.99%
Cash From Operating Activities	$29.63M	$123.5M
YoY Change	-40.26%	3.34%
INVESTING ACTIVITIES
Capital Expenditures	$7.588M	$17.19M
YoY Change	-9.98%	-19.36%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	-$30.84M	-$108.1M
YoY Change	-7.07%	36.99%
Cash From Investing Activities	-$38.53M	-$125.3M
YoY Change	-7.42%	25.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$112.0K
YoY Change		-99.48%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	10.00K	$10.00K
YoY Change	-100.07%	-100.03%
NET CHANGE
Cash From Operating Activities	29.63M	$123.5M
Cash From Investing Activities	-38.53M	-$125.3M
Cash From Financing Activities	10.00K	$10.00K
Net Change In Cash	-8.890M	-$4.147M
YoY Change	26.71%	-72.31%
FREE CASH FLOW
Cash From Operating Activities	$29.63M	$123.5M
Capital Expenditures	$7.588M	$17.19M
Free Cash Flow	$22.04M	$106.3M
YoY Change	-46.45%	8.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-30668
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	L3
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	5 David Fikes St.
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Rehovot
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	7632805
CY2023	dei	Entity Address Country EntityAddressCountry	IL
CY2023	dei	Security12b Title Security12bTitle	Ordinary Shares
CY2023	dei	Trading Symbol TradingSymbol	NVMI
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	29013837	shares
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Firm AuditorFirmId	1281
CY2023	dei	Auditor Name AuditorName	KOST FORER GABBAY & KASIERER
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	111121000	usd
CY2023Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	119850000	usd
CY2022Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	95305000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	216258000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	167073000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	277000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	215000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	111256000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	109320000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	138198000	usd
CY2023Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	6254000	usd
CY2022Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	2083000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	23583000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	20097000	usd
CY2023Q4	nvmi	Severance Pay Funds Noncurrent SeverancePayFundsNoncurrent	1146000	usd
CY2022Q4	nvmi	Severance Pay Funds Noncurrent SeverancePayFundsNoncurrent	1194000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	41856000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	44885000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	66874000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	55886000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	39184000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	43586000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3259000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	957000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	423587000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	371159000	usd
CY2023Q4	us-gaap	Assets Assets	1133807000	usd
CY2022Q4	us-gaap	Assets Assets	984105000	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	197678000	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	35158000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	42732000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	41978000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	30543000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6703000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5968000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	41294000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	54825000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	322811000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	134068000	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	196394000	usd
CY2023Q4	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	3363000	usd
CY2022Q4	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	3599000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	39762000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	43697000	usd
CY2023Q4	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	10574000	usd
CY2022Q4	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	12190000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7194000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	60244000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	263074000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29013834	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29013834	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28678476	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28678476	shares
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	139694000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	121398000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3325000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-12508000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	478073000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	750752000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	586963000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	984105000	usd
CY2023	us-gaap	Revenues Revenues	517922000	usd
CY2022	us-gaap	Revenues Revenues	570729000	usd
CY2021	us-gaap	Revenues Revenues	416113000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	224745000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	253759000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	180670000	usd
CY2023	us-gaap	Gross Profit GrossProfit	293177000	usd
CY2022	us-gaap	Gross Profit GrossProfit	316970000	usd
CY2021	us-gaap	Gross Profit GrossProfit	235443000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	88043000	usd
CY2022	nvmi	Financing Income Net FinancingIncomeNet	8478000	usd
CY2021	nvmi	Financing Income Net FinancingIncomeNet	-3133000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	154699000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	158409000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	109253000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18389000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18196000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16152000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	136310000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	140213000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	93101000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.73
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.89
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.28
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.28
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28697	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28372	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32089	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31870	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29816	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	136310000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	140213000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	93101000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	2946000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-5039000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	0	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	5193000	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-6047000	usd
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-1016000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-532000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-2421000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-1576000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-1813000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	442000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	9183000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1384000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	145493000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	128519000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	91717000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	371538000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11000	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2021	nvmi	Adjustment To Additional Paid In Capital Elimination Of Par Value Of Ordinary Shares AdjustmentToAdditionalPaidInCapitalEliminationOfParValueOfOrdinaryShares	0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1384000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	93101000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	473754000	usd
CY2022	nvmi	Increase Decrease Due To Accounting Standard Adoption Effect Adjustment IncreaseDecreaseDueToAccountingStandardAdoptionEffectAdjustment	-10631000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	90000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16647000	usd
CY2022	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	21416000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11694000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	586963000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	136310000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	140213000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	93101000	usd
CY2022	us-gaap	Depreciation Depreciation	8621000	usd
CY2021	us-gaap	Depreciation Depreciation	6475000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5857000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6033000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2458000	usd
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	3001000	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-1666000	usd
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-1708000	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1284000	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1282000	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4229000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	18286000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	16647000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	10488000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4223000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-192000	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-6241000	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-13740000	usd
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-2989000	usd
CY2023	nvmi	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	3050000	usd
CY2022	nvmi	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	3873000	usd
CY2021	nvmi	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	1680000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-7807000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	5142000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	11697000	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	11391000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	15243000	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	10621000	usd
CY2023	nvmi	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-3221000	usd
CY2022	nvmi	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-6351000	usd
CY2021	nvmi	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-904000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-11352000	usd
CY2023	nvmi	Change In Short Term And Long Term Interest Bearing Bank Deposits ChangeInShortTermAndLongTermInterestBearingBankDeposits	29658000	usd
CY2022	nvmi	Change In Short Term And Long Term Interest Bearing Bank Deposits ChangeInShortTermAndLongTermInterestBearingBankDeposits	-129944000	usd
CY2021	nvmi	Change In Short Term And Long Term Interest Bearing Bank Deposits ChangeInShortTermAndLongTermInterestBearingBankDeposits	31456000	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	273572000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	211742000	usd
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	215091000	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	195087000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	81325000	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	12862000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21314000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4816000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-100256000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-238501000	usd
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	8480000	usd
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	112000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	21416000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	122000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	90000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-29806000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14977000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-105606000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	111721000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	126698000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	232304000	usd
CY2022	nvmi	Operating Right Of Use Assets Recognized With Corresponding Operating Lease Liabilities OperatingRightOfUseAssetsRecognizedWithCorrespondingOperatingLeaseLiabilities	17398000	usd
CY2021	nvmi	Operating Right Of Use Assets Recognized With Corresponding Operating Lease Liabilities OperatingRightOfUseAssetsRecognizedWithCorrespondingOperatingLeaseLiabilities	3198000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	26842000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	23014000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	13275000	usd
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	107574000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	111121000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	600000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	107574000	usd
CY2021	nvmi	Research And Development Grants Recognized ResearchAndDevelopmentGrantsRecognized	4395000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	10999000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9107000	usd
CY2023Q4	nvmi	Governmental Institutions Current GovernmentalInstitutionsCurrent	3682000	usd
CY2022Q4	nvmi	Governmental Institutions Current GovernmentalInstitutionsCurrent	2889000	usd
CY2023Q4	nvmi	Governments Grants Receivables GovernmentsGrantsReceivables	662000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0089	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	299249	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	265085	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	336857	shares
CY2022Q4	nvmi	Governments Grants Receivables GovernmentsGrantsReceivables	1416000	usd
CY2023Q4	nvmi	Other Assets Classified As Current OtherAssetsClassifiedAsCurrent	512000	usd
CY2022Q4	nvmi	Other Assets Classified As Current OtherAssetsClassifiedAsCurrent	115000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	409746000	usd
CY2023	us-gaap	Available For Sale Debt Securities Gross Unrealized Gain AvailableForSaleDebtSecuritiesGrossUnrealizedGain	775000	usd
CY2023	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	2912000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	407609000	usd
CY2022	us-gaap	Available For Sale Debt Securities Gross Unrealized Gain AvailableForSaleDebtSecuritiesGrossUnrealizedGain	29000	usd
CY2022	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	8087000	usd
CY2023	nvmi	Proceeds From Maturity Of Available For Sale Marketable Securities ProceedsFromMaturityOfAvailableForSaleMarketableSecurities	192585000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	17084000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	13527000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	129986000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	109783000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	63112000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	24762000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	26805000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	138198000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	116600000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	8748000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	6406000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	5126000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	66874000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	55886000	usd
CY2023	us-gaap	Depreciation Depreciation	10344000	usd
CY2022	us-gaap	Depreciation Depreciation	8621000	usd
CY2021	us-gaap	Depreciation Depreciation	6475000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5857000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6033000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2458000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5782000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	5285000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	5285000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	5285000	usd
CY2023Q4	nvmi	Finite Lived Future Amortization Intangible Assets FiniteLivedFutureAmortizationIntangibleAssets	39184000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	31652000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	8080000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	9517000	usd
CY2022Q4	nvmi	Amount Of Obligation To Governmental Institutions AmountOfObligationToGovernmentalInstitutions	12202000	usd
CY2023Q4	nvmi	Amount Of Obligation To Governments Grants Payables AmountOfObligationToGovernmentsGrantsPayables	1019000	usd
CY2022Q4	nvmi	Amount Of Obligation To Governments Grants Payables AmountOfObligationToGovernmentsGrantsPayables	647000	usd
CY2023Q4	nvmi	Other Assets Current Other OtherAssetsCurrentOther	244000	usd
CY2022Q4	nvmi	Other Assets Current Other OtherAssetsCurrentOther	353000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	41294000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	54825000	usd
CY2022	us-gaap	Standard Product Warranty Accrual Period Increase Decrease StandardProductWarrantyAccrualPeriodIncreaseDecrease	13704000	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	8523000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	10630000	usd
CY2022	us-gaap	Severance Costs1 SeveranceCosts1	1114000	usd
CY2021	us-gaap	Severance Costs1 SeveranceCosts1	818000	usd
CY2023	nvmi	Amount Of Increase Liability For Convertible Senior Notes AmountOfIncreaseLiabilityForConvertibleSeniorNotes	12075000	usd
CY2023	nvmi	Amount Of Reduction Of Additional Paid Capital AmountOfReductionOfAdditionalPaidCapital	13770000	usd
CY2023	nvmi	Amount Of Increase To Deferred Tax Assets AmountOfIncreaseToDeferredTaxAssets	1444000	usd
CY2023	nvmi	Amount Of Cumulative Effect Adjustment Of Income Tax Effects AmountOfCumulativeEffectAdjustmentOfIncomeTaxEffects	3139000	usd
CY2023	nvmi	Amount Of Reduced Interest Expense AmountOfReducedInterestExpense	3147000	usd
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2680965000	shares
CY2023Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.007	pure
CY2023	us-gaap	Lessor Operating Lease Option To Extend LessorOperatingLeaseOptionToExtend	up to additional 10 years
CY2023Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P12Y7M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.037	pure
CY2023	us-gaap	Lease Cost LeaseCost	6636000	usd
CY2022	us-gaap	Lease Cost LeaseCost	6587000	usd
CY2021	us-gaap	Lease Cost LeaseCost	3935000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	6257000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5422000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5345000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5415000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	30681000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	59879000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	13414000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	46465000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	6138000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	6450000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	4134000	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	21528000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18286000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16647000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10488000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	35.94
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	39.61
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	106279	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	31.04
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	100540	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	29.4
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	11302000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	15271000	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	10857000	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	12956000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	11149000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	14523000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	18571000	usd
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	106279	shares
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	31.04
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	100540	shares
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	29.4
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001109345
CY2023	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#OperatingExpenses
CY2022	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#OperatingExpenses
CY2021	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#OperatingExpenses
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Entity Registrant Name EntityRegistrantName	NOVA LTD.
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	true
CY2023	dei	Document Fin Stmt Restatement Recovery Analysis Flag DocumentFinStmtRestatementRecoveryAnalysisFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Auditor Location AuditorLocation	Tel-Aviv, Israel
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	107574000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	116600000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	17084000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	13527000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	710220000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	612946000	usd
CY2023Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	191351000	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	153462000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	50080000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	49009000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6545000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Liabilities Liabilities	383055000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	397142000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	614383000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1133807000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	90458000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	65857000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	52467000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	52729000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	39876000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20404000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23852000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17324000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	160914000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	167039000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	123057000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	132263000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	149931000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	112386000	usd
CY2023	nvmi	Financing Income Net FinancingIncomeNet	22436000	usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.43
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.12
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28828	shares
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	74000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11694000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10488000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	140213000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	122000	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18286000	usd
CY2023	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	112000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	9183000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	136310000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	750752000	usd
CY2023	us-gaap	Depreciation Depreciation	10344000	usd
CY2023	nvmi	Net Effect Of Exchange Rate Fluctuation NetEffectOfExchangeRateFluctuation	1754000	usd
CY2022	nvmi	Net Effect Of Exchange Rate Fluctuation NetEffectOfExchangeRateFluctuation	4523000	usd
CY2021	nvmi	Net Effect Of Exchange Rate Fluctuation NetEffectOfExchangeRateFluctuation	-745000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1183000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	31634000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5132000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	26000000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	29311000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	18457000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5752000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1509000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	17919000	usd
CY2023	us-gaap	Increase Decrease In Postemployment Obligations IncreaseDecreaseInPostemploymentObligations	-188000	usd
CY2022	us-gaap	Increase Decrease In Postemployment Obligations IncreaseDecreaseInPostemploymentObligations	46000	usd
CY2021	us-gaap	Increase Decrease In Postemployment Obligations IncreaseDecreaseInPostemploymentObligations	-79000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	123531000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	119539000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	132262000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	78469000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17188000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-125331000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-2357000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-4454000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	622000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4147000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	107574000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	111721000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	126698000	usd
CY2023	nvmi	Operating Right Of Use Assets Recognized With Corresponding Operating Lease Liabilities OperatingRightOfUseAssetsRecognizedWithCorrespondingOperatingLeaseLiabilities	785000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	126698000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	111721000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	126698000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.3902	pure
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:56.7pt;font-family:'Times New Roman',Times,serif"><span style="font-size:12pt"><span style="font-family:Times New Roman,Times,serif"><span> </span></span></span></td> <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold;font-size:12pt"><span style="font-size:12pt"><span style="font-family:Times New Roman,Times,serif">B.</span></span></td> <td style="width:auto;vertical-align:top;text-align:justify;font-family:'Times New Roman',Times,serif"> <div style="font-weight:bold;font-size:12pt;margin-bottom:0pt"><span style="font-size:12pt"><span style="font-family:Times New Roman,Times,serif">Use of Estimates in the Preparation of Financial Statements</span></span></div> </td> </tr> <tr> <td style="width:56.7pt;font-family:'Times New Roman',Times,serif"> </td> <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold;font-size:12pt"> </td> <td style="width:auto;vertical-align:top;text-align:justify;font-family:'Times New Roman',Times,serif"> </td> </tr> </table> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:12pt"><span style="font-size:12pt"><span style="font-family:Times New Roman,Times,serif">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. The Company's management evaluates its estimates on an ongoing basis, including those related to, but not limited to revenue recognition, allowance for credit losses related to marketable securities, inventory write-offs, business combination, fair value and useful lives of intangible assets, income taxes and tax uncertainties income taxes, credit loss related to collectability of trade accounts receivable, goodwill impairment, lease discount rate and lease period. These estimates are based on management's knowledge about current events and expectations about actions the Company may undertake in the future. Actual results could differ from those estimates.</span></span><span style="font-size:12pt"><span style="font-family:Times New Roman,Times,serif"><span> </span></span></span></div> </div>
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023	nvmi	Capitalized Implementation Costs CapitalizedImplementationCosts	2463000	usd
CY2023Q4	nvmi	Remaining Performance Obligations RemainingPerformanceObligations	65509000	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	41978000	usd
CY2023Q4	nvmi	Uncollected Amounts Of Deferred Revenue UncollectedAmountsOfDeferredRevenue	23531000	usd
CY2023	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	27065000	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	12924000	usd
CY2021	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	3651000	usd
CY2023	nvmi	Research And Development Grants Recognized ResearchAndDevelopmentGrantsRecognized	3061000	usd
CY2022	nvmi	Research And Development Grants Recognized ResearchAndDevelopmentGrantsRecognized	3064000	usd
CY2023	nvmi	Degree Of Likelihood Of Sustaining Uncertain Tax Position Threshold For Recognition Percent DegreeOfLikelihoodOfSustainingUncertainTaxPositionThresholdForRecognitionPercent	0.50	pure
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y11M19D
CY2023	us-gaap	Net Income Loss NetIncomeLoss	136310000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	140213000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	93101000	usd
CY2023	nvmi	Amortization Of Debt Issuance Costs Related To Convertible Notes AmortizationOfDebtIssuanceCostsRelatedToConvertibleNotes	1130000	usd
CY2022	nvmi	Amortization Of Debt Issuance Costs Related To Convertible Notes AmortizationOfDebtIssuanceCostsRelatedToConvertibleNotes	1128000	usd
CY2021	nvmi	Amortization Of Debt Issuance Costs Related To Convertible Notes AmortizationOfDebtIssuanceCostsRelatedToConvertibleNotes	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	137440000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	141341000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	93101000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28828	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28697	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28372	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	580	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	492	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	819	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	2681	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	2681	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	625	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32089	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31870	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29816	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.73
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.89
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.28
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.28
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.43
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.12
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.43
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:56.7pt;font-family:'Times New Roman',Times,serif"><span style="font-size:12pt"><span style="font-family:Times New Roman,Times,serif"><span> </span></span></span></td> <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold;font-size:12pt"><span style="font-size:12pt"><span style="font-family:Times New Roman,Times,serif">W.</span></span></td> <td style="width:auto;vertical-align:top;text-align:justify;font-family:'Times New Roman',Times,serif"> <div style="font-weight:bold;font-size:12pt"><span style="font-size:12pt"><span style="font-family:Times New Roman,Times,serif">Concentrations of Credit Risk</span></span></div> </td> </tr> <tr> <td style="width:56.7pt;font-family:'Times New Roman',Times,serif"> </td> <td style="width:28.35pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold;font-size:12pt"> </td> <td style="width:auto;vertical-align:top;text-align:justify;font-family:'Times New Roman',Times,serif"> </td> </tr> </table> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:12pt"><span style="font-size:12pt"><span style="font-family:Times New Roman,Times,serif">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, bank deposits, marketable securities, trade accounts receivable and foreign currency derivative contracts.</span></span></div> <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:12pt"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:12pt"><span style="font-size:12pt"><span style="font-family:Times New Roman,Times,serif">The majority of the Company’s cash and cash equivalents and bank deposits are invested in dollar instruments with major banks in Israel. Management believes that the financial institutions that hold the Company's investments are corporations with high credit standing. Accordingly, management believes that low credit risk exists with respect to these financial investments.</span></span></div> <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:12pt"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:Arial, sans-serif"><span style="font-size:12pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0)">The trade accounts receivable of the Company are derived from sales to customers located primarily in </span><span>Taiwan R.O.C.<span style="color:rgb(0, 0, 0)">, </span>Korea, China <span style="color:rgb(0, 0, 0)">and USA. The management of the Company performed risk assessment on an ongoing basis and believes it bears low risk.</span></span></span></span></div> <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:12pt"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:12pt"><span style="font-size:12pt"><span style="font-family:Times New Roman,Times,serif">The Company entered into options and forward contracts to hedge against the risk of overall changes in future cash flow from payments of payroll and related expenses as well as other expenses denominated in NIS. The derivative instruments hedge a portion of the Company's non-dollar currency exposure. Counterparty to the Company’s derivative instruments is major financial institution.</span></span></div> <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:12pt"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:12pt"><span style="font-size:12pt"><span style="font-family:Times New Roman,Times,serif">The Company's debt marketable securities include investments in highly rated corporate debentures and governmental bonds. The financial institutions that hold the Company's debt marketable securities are major financial institutions located in the United States. The Company believes its debt marketable securities portfolio is a diverse portfolio of highly rated securities and the Company's investment policy limits the amount the Company may invest in an issuer.</span></span></div> </div>
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	328593000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	320535000	usd
CY2022	nvmi	Proceeds From Maturity Of Available For Sale Marketable Securities ProceedsFromMaturityOfAvailableForSaleMarketableSecurities	80391000	usd
CY2023	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2502000	usd
CY2022	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	934000	usd
CY2023	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	35000	usd
CY2022	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	68000	usd
CY2023	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	2912000	usd
CY2023	nvmi	Available For Sale Equity Securities Gross Unrealized Loss Part Included In Previous Year AvailableForSaleEquitySecuritiesGrossUnrealizedLossPartIncludedInPreviousYear	2692000	usd
CY2022	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	8087000	usd
CY2022	nvmi	Available For Sale Equity Securities Gross Unrealized Loss Part Included In Previous Year AvailableForSaleEquitySecuritiesGrossUnrealizedLossPartIncludedInPreviousYear	1191000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	50156000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	38050000	usd
CY2023Q4	nvmi	Service Inventory ServiceInventory	31407000	usd
CY2022Q4	nvmi	Service Inventory ServiceInventory	26069000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	31873000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	25676000	usd
CY2023Q4	us-gaap	Derivative Instruments In Hedges Assets At Fair Value DerivativeInstrumentsInHedgesAssetsAtFairValue	1229000	usd
CY2022Q4	us-gaap	Derivative Instruments In Hedges Assets At Fair Value DerivativeInstrumentsInHedgesAssetsAtFairValue	0	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	53897000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	67974000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	66519000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	28790000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	22933000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	39184000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	43586000	usd
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	8885000	usd
CY2023	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	11764000	usd
CY2022	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	11959000	usd
CY2023	us-gaap	Standard Product Warranty Accrual Period Increase Decrease StandardProductWarrantyAccrualPeriodIncreaseDecrease	9657000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	5285000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	12262000	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	27105000	usd
CY2023Q4	nvmi	Amount Of Obligation To Governmental Institutions AmountOfObligationToGovernmentalInstitutions	4846000	usd
CY2023Q4	us-gaap	Derivative Instruments In Hedges Liabilities At Fair Value DerivativeInstrumentsInHedgesLiabilitiesAtFairValue	0	usd
CY2022Q4	us-gaap	Derivative Instruments In Hedges Liabilities At Fair Value DerivativeInstrumentsInHedgesLiabilitiesAtFairValue	454000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	8080000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	9517000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	443000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	1113000	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	8523000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	10630000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	10630000	usd
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	957000	usd
CY2022	nvmi	Amount Of Reduced Interest Expense AmountOfReducedInterestExpense	3053000	usd
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2055641000	shares
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1284000	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1282000	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4229000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	6759000	usd
CY2023Q4	us-gaap	Purchase Obligation PurchaseObligation	105300000	usd
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000000	usd
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	252983	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	290711	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	29.83
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	133485	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	25.2
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	50947	shares
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	13009000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	7907000	usd
CY2023	nvmi	Percent Of Income Required From Export PercentOfIncomeRequiredFromExport	0.25	pure
CY2023	nvmi	Withholding Tax On Dividends WithholdingTaxOnDividends	0.15	pure
CY2021	nvmi	Trapped Profits Agreement Net Effect TrappedProfitsAgreementNetEffect	3700000	usd
CY2023	nvmi	Taxable Income In Israel Is Attributable To Preferred Enterprises Tax Rate TaxableIncomeInIsraelIsAttributableToPreferredEnterprisesTaxRate	0.16	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	412000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	1080000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	2872000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	1610000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	9853000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	10058000	usd
CY2023Q4	nvmi	Deferred Tax Assets Operating Lease Liabilities Net DeferredTaxAssetsOperatingLeaseLiabilitiesNet	2494000	usd
CY2022Q4	nvmi	Deferred Tax Assets Operating Lease Liabilities Net DeferredTaxAssetsOperatingLeaseLiabilitiesNet	3178000	usd
CY2023Q4	nvmi	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	14842000	usd
CY2022Q4	nvmi	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	10176000	usd
CY2023Q4	nvmi	Total Net Deferred Tax Asset Before Valuation Allowance TotalNetDeferredTaxAssetBeforeValuationAllowance	30473000	usd
CY2022Q4	nvmi	Total Net Deferred Tax Asset Before Valuation Allowance TotalNetDeferredTaxAssetBeforeValuationAllowance	26102000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2790000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2098000	usd
CY2023Q4	nvmi	Total Net Deferred Tax Asset After Valuation Allowance TotalNetDeferredTaxAssetAfterValuationAllowance	27683000	usd
CY2022Q4	nvmi	Total Net Deferred Tax Asset After Valuation Allowance TotalNetDeferredTaxAssetAfterValuationAllowance	24004000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	11346000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	12539000	usd
CY2023Q4	nvmi	Deferred Tax Liabilities Operating Lease Right Of Use Assets DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets	1936000	usd
CY2022Q4	nvmi	Deferred Tax Liabilities Operating Lease Right Of Use Assets DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets	2631000	usd
CY2023Q4	nvmi	Deferred Tax Liabilities Reserve And Allowances DeferredTaxLiabilitiesReserveAndAllowances	1392000	usd
CY2022Q4	nvmi	Deferred Tax Liabilities Reserve And Allowances DeferredTaxLiabilitiesReserveAndAllowances	927000	usd
CY2023Q4	nvmi	Total Net Deferred Tax Liabilities Before Valuation Allowance TotalNetDeferredTaxLiabilitiesBeforeValuationAllowance	14674000	usd
CY2022Q4	nvmi	Total Net Deferred Tax Liabilities Before Valuation Allowance TotalNetDeferredTaxLiabilitiesBeforeValuationAllowance	16097000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	13009000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	7907000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	23583000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	20097000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	10574000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	12190000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	13009000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	7907000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	154699000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	158409000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	109253000	usd
CY2023	nvmi	Current Domestic Tax Expense Benefit CurrentDomesticTaxExpenseBenefit	17363000	usd
CY2022	nvmi	Current Domestic Tax Expense Benefit CurrentDomesticTaxExpenseBenefit	15868000	usd
CY2021	nvmi	Current Domestic Tax Expense Benefit CurrentDomesticTaxExpenseBenefit	12297000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1026000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	2328000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	3855000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18389000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18196000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16152000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	24845000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	32323000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	19311000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-6456000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-14127000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3159000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18389000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18196000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16152000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	154699000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	158409000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	109253000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	18564000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	19009000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	13110000	usd
CY2023	nvmi	Income Tax Reconciliation Effect Of Nonbeneficial Income New Technological Or Approved Or Preferred Enterprises Statuses In Israel IncomeTaxReconciliationEffectOfNonbeneficialIncomeNewTechnologicalOrApprovedOrPreferredEnterprisesStatusesInIsrael	657000	usd
CY2022	nvmi	Income Tax Reconciliation Effect Of Nonbeneficial Income New Technological Or Approved Or Preferred Enterprises Statuses In Israel IncomeTaxReconciliationEffectOfNonbeneficialIncomeNewTechnologicalOrApprovedOrPreferredEnterprisesStatusesInIsrael	335000	usd
CY2021	nvmi	Income Tax Reconciliation Effect Of Nonbeneficial Income New Technological Or Approved Or Preferred Enterprises Statuses In Israel IncomeTaxReconciliationEffectOfNonbeneficialIncomeNewTechnologicalOrApprovedOrPreferredEnterprisesStatusesInIsrael	88000	usd
CY2023	nvmi	Income Tax Reconciliation Permanent Differences Including Difference Between Basis Of Measurement Of Income Reported For Tax Purposes And Basis Of Measurement Of Income For Financial Reporting Purposes Net IncomeTaxReconciliationPermanentDifferencesIncludingDifferenceBetweenBasisOfMeasurementOfIncomeReportedForTaxPurposesAndBasisOfMeasurementOfIncomeForFinancialReportingPurposesNet	-384000	usd
CY2022	nvmi	Income Tax Reconciliation Permanent Differences Including Difference Between Basis Of Measurement Of Income Reported For Tax Purposes And Basis Of Measurement Of Income For Financial Reporting Purposes Net IncomeTaxReconciliationPermanentDifferencesIncludingDifferenceBetweenBasisOfMeasurementOfIncomeReportedForTaxPurposesAndBasisOfMeasurementOfIncomeForFinancialReportingPurposesNet	-1131000	usd
CY2021	nvmi	Income Tax Reconciliation Permanent Differences Including Difference Between Basis Of Measurement Of Income Reported For Tax Purposes And Basis Of Measurement Of Income For Financial Reporting Purposes Net IncomeTaxReconciliationPermanentDifferencesIncludingDifferenceBetweenBasisOfMeasurementOfIncomeReportedForTaxPurposesAndBasisOfMeasurementOfIncomeForFinancialReportingPurposesNet	-448000	usd
CY2023	nvmi	Income Tax Reconciliation Change In Tax Reserve For Uncertain Tax Positions IncomeTaxReconciliationChangeInTaxReserveForUncertainTaxPositions	-625000	usd
CY2022	nvmi	Income Tax Reconciliation Change In Tax Reserve For Uncertain Tax Positions IncomeTaxReconciliationChangeInTaxReserveForUncertainTaxPositions	-51000	usd
CY2021	nvmi	Income Tax Reconciliation Change In Tax Reserve For Uncertain Tax Positions IncomeTaxReconciliationChangeInTaxReserveForUncertainTaxPositions	-713000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	4070000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	3477000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	3249000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Fdii Amount EffectiveIncomeTaxRateReconciliationFdiiAmount	2497000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Fdii Amount EffectiveIncomeTaxRateReconciliationFdiiAmount	2483000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Fdii Amount EffectiveIncomeTaxRateReconciliationFdiiAmount	1785000	usd
CY2023	nvmi	Income Tax Reconciliation Tax Credit IncomeTaxReconciliationTaxCredit	1801000	usd
CY2022	nvmi	Income Tax Reconciliation Tax Credit IncomeTaxReconciliationTaxCredit	1640000	usd
CY2021	nvmi	Income Tax Reconciliation Tax Credit IncomeTaxReconciliationTaxCredit	1592000	usd
CY2023	nvmi	Trapped Profits Agreement Net Effect TrappedProfitsAgreementNetEffect	0	usd
CY2022	nvmi	Trapped Profits Agreement Net Effect TrappedProfitsAgreementNetEffect	0	usd
CY2021	nvmi	Trapped Profits Agreement Net Effect TrappedProfitsAgreementNetEffect	3716000	usd
CY2023	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-651000	usd
CY2022	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-172000	usd
CY2021	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-113000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	871000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	692000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	601000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	185000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	160000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	39000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-175000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-813000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	3042000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18389000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18196000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16152000	usd
CY2023Q4	us-gaap	Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries	34652000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9276000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	8674000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	2884000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1202000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	3030000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1804000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9422000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9276000	usd
CY2023	nvmi	Unrecognized Tax Benefits Presented As Reduction From Deferred Tax Assets UnrecognizedTaxBenefitsPresentedAsReductionFromDeferredTaxAssets	2799000	usd
CY2022	nvmi	Unrecognized Tax Benefits Presented As Reduction From Deferred Tax Assets UnrecognizedTaxBenefitsPresentedAsReductionFromDeferredTaxAssets	2590000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23	pure
CY2023Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	36706000	usd
CY2022Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	85293000	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1576000	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1813000	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-453000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	22643000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	6478000	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2194000	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	1284000	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	1282000	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	4229000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	1303000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	3469000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-948000	usd
CY2023	nvmi	Bank Charges BankCharges	226000	usd
CY2022	nvmi	Bank Charges BankCharges	187000	usd
CY2021	nvmi	Bank Charges BankCharges	150000	usd
CY2023	nvmi	Financing Income Net FinancingIncomeNet	22436000	usd
CY2022	nvmi	Financing Income Net FinancingIncomeNet	8478000	usd
CY2021	nvmi	Financing Income Net FinancingIncomeNet	-3133000	usd

Files In Submission

Name	View Source	Status
0001178913-24-000649-index-headers.html	Edgar Link	pending
0001178913-24-000649-index.html	Edgar Link	pending
0001178913-24-000649.txt	Edgar Link	pending
0001178913-24-000649-xbrl.zip	Edgar Link	pending
exhibit_12-1.htm	Edgar Link	pending
exhibit_12-2.htm	Edgar Link	pending
exhibit_13-1.htm	Edgar Link	pending
exhibit_13-2.htm	Edgar Link	pending
exhibit_15-1.htm	Edgar Link	pending
exhibit_8-1.htm	Edgar Link	pending
exhibit_97.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nvmi-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nvmi-20231231_cal.xml	Edgar Link	unprocessable
nvmi-20231231_def.xml	Edgar Link	unprocessable
nvmi-20231231_pre.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zk2430914.htm	Edgar Link	pending
zk2430914_htm.xml	Edgar Link	completed
nvmi-20231231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NVMI
NOVA LTD. Stock $nvmi

2023 Q4 Form 20-F Financial Statement

#000117891324000649 Filed on February 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVMI NOVA LTD. Stock $nvmi

2023 Q4 Form 20-F Financial Statement

#000117891324000649 Filed on February 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVMI
NOVA LTD. Stock $nvmi